Reynolds American Appoints Dawn-Marie Hutchinson as Senior Vice President and Chief Information Officer

Sep.11.2025
Reynolds American Inc. has appointed Dawn-Marie Hutchinson as Senior Vice President and Chief Information Officer, effective October 1, 2025. She will lead the company’s technology, data, and cybersecurity strategy, bringing experience from BAT, GSK, and Urban Outfitters.

Key Points

 

  • Appointment: Dawn-Marie Hutchinson named SVP & CIO of Reynolds American Inc., effective October 1, 2025.

 

  • Scope: Leads technology strategy, including digital workplace, data & analytics, and cybersecurity.

 

  • Background: Former CISO at GSK and Urban Outfitters; joined BAT Group in 2021.

 


 

September 11, 2025 — Reynolds American Inc. (Reynolds), the U.S. subsidiary of the global BAT Group, announced the appointment of Dawn-Marie Hutchinson as Senior Vice President and Chief Information Officer, effective October 1, 2025.

 

In this role, Hutchinson will lead the company’s technology strategy and operations, encompassing digital workplace, core platforms, data & analytics, cybersecurity, and IT service delivery. She will also serve on the Reynolds American Leadership Team.

 

Hutchinson joined the BAT Group in 2021 after a successful career as a Chief Information Security Officer with extensive experience in multinational manufacturing and consumer goods companies. Before joining BAT, she served as CISO for Pharmaceuticals, R&D, and Supply Chain at GlaxoSmithKline (GSK), and earlier as CISO at Urban Outfitters Group. She began her career as a Business Analyst at The Walt Disney Company.

 

Reynolds American Appoints Dawn-Marie Hutchinson as Senior Vice President and Chief Information Officer
Dawn-Marie Hutchinson|Image source:Reynolds American

 

During her time at BAT, Hutchinson significantly expanded the global cybersecurity program by establishing a regional support model, launching the Cyber Defense Centre, accelerating the Operational Technology cyber program, and transforming the governance, risk, and compliance function.

 

In her new position, Hutchinson will lead efforts to modernize Reynolds’ IT landscape, strengthen operational resilience, and drive value creation through data and AI across the company’s operating businesses.

 

In addition to her role within BAT Group, Hutchinson serves as a non-executive director on the board of Xalient.


A native of New Hampshire, she holds a Bachelor of Arts in Political Science from the University of New Hampshire and an MBA from Saint Joseph’s University in Philadelphia.

 

Reynolds American Inc. is a wholly owned subsidiary of the global BAT Group, serving as the U.S. parent company of R.J. Reynolds Tobacco Company, Santa Fe Natural Tobacco Company, American Snuff Company, R.J. Reynolds Vapor Company, and Modoral Brands Inc.

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
Based on public records reviewed by 2Firsts, this is the first time China’s State Tobacco Monopoly Administration has publicly announced regulatory talks with an e-cigarette company.
Jul.29
Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Product | PMI Japan Launches SENTIA Passion Fruit Capsule, Expanding the IQOS ILUMA Flavor Portfolio
Philip Morris Japan (PM Japan) has introduced SENTIA Passion Fruit Capsule, a new tobacco stick designed for the IQOS ILUMA heated tobacco platform. Featuring a crush-activated capsule, the product combines menthol with passion fruit flavor to provide an additional flavor experience. The product launched in Japan from August 3, 2026, through IQOS official channels, convenience stores and tobacco retailers.
Aug.04
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01